In late December 2023, the World Health Organization issued its first-ever prequalification approval for a vaccine being used under its Emergency Use Listing (EUL) regulatory pathway – novel oral polio vaccine type 2 (nOPV2). Since rollout of the vaccine in March 2021, the Global Polio Eradication Initiative (GPEI) has administered nearly 1 billion doses across 35 countries.
